T‐Cell‐Derived Nanovesicles for Cancer Immunotherapy-Reference-Cited by-同舟云学术

T‐Cell‐Derived Nanovesicles for Cancer Immunotherapy

Published:2021-07-08 Issue:33 Volume:33 Page:2101110
ISSN:0935-9648
Container-title:Advanced Materials
language:en
Short-container-title:Adv. Mater.

Author:

Hong Jihye¹,Kang Mikyung¹,Jung Mungyo²,Lee Yun Young³,Cho Yongbum⁴,Kim Cheesue²,Song Seuk Young²,Park Chun Gwon⁵,Doh Junsang⁶,Kim Byung‐Soo¹²⁷^ORCID

Affiliation:

1. Interdisciplinary Program for Bioengineering Seoul National University Seoul 08826 Republic of Korea

2. School of Chemical and Biological Engineering Seoul National University Seoul 08826 Republic of Korea

3. Department of Biomedical Engineering Seoul National University College of Medicine Seoul 03080 Republic of Korea

4. School of Interdisciplinary Bioscience and Bioengineering (I‐Bio) Pohang University of Science and Technology (POSTECH) Pohang 37673 Republic of Korea

5. Department of Biomedical Engineering SKKU Institute for Convergence Sungkyunkwan University Suwon 16419 Republic of Korea

6. Department of Materials Science and Engineering Seoul National University Seoul 08826 Republic of Korea

7. Institute of Chemical Processes Institute of Engineering Research and BioMAX Seoul National University Seoul 08826 Republic of Korea

Funder

National Research Foundation of Korea

Seoul National University

Publisher

Wiley

Subject

Mechanical Engineering,Mechanics of Materials,General Materials Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adma.202101110

Reference42 articles.

1. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

2. Chimeric antigen receptor T-cell therapies for lymphoma

3. Mechanisms of resistance to CAR T cell therapy

4. Granzyme B: a natural born killer

5. Exhaustion of T lymphocytes in the tumor microenvironment: Significance and effective mechanisms

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing cancer treatment via bioengineered extracellular vesicles: Exploring nanovesicles to fully synthetic solutions;Applied Materials Today;2024-10

2. Non-viral gene therapy for neuromuscular diseases including Duchenne muscular dystrophy using nanovesicles derived from human cells;Rare Disease and Orphan Drugs Journal;2024-09-02

3. Hybrid nanovesicles comprising induced pluripotent stem cells and dendritic cell-derived exosomes enhance antitumor immunity;Chemical Engineering Journal;2024-09

4. Multi-modal Ca2+ nanogenerator via reversing T cell exhaustion for enhanced chemo-immunotherapy;Journal of Controlled Release;2024-08

5. M1-polarized macrophage-derived cellular nanovesicle-coated lipid nanoparticles for enhanced cancer treatment through hybridization of gene therapy and cancer immunotherapy;Acta Pharmaceutica Sinica B;2024-07